These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24594601)

  • 1. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.
    Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
    Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
    Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs6983267 SNP and long non-coding RNA CARLo-5 are associated with endometrial carcinoma.
    Zhao X; Wei X; Zhao L; Shi L; Cheng J; Kang S; Zhang H; Zhang J; Li L; Zhang H; Zhao W
    Environ Mol Mutagen; 2016 Aug; 57(7):508-15. PubMed ID: 27432114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range enhancers on 8q24 regulate c-Myc.
    Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
    Wasserman NF; Aneas I; Nobrega MA
    Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.
    Betts JA; Moradi Marjaneh M; Al-Ejeh F; Lim YC; Shi W; Sivakumaran H; Tropée R; Patch AM; Clark MB; Bartonicek N; Wiegmans AP; Hillman KM; Kaufmann S; Bain AL; Gloss BS; Crawford J; Kazakoff S; Wani S; Wen SW; Day B; Möller A; Cloonan N; Pearson J; Brown MA; Mercer TR; Waddell N; Khanna KK; Dray E; Dinger ME; Edwards SL; French JD
    Am J Hum Genet; 2017 Aug; 101(2):255-266. PubMed ID: 28777932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
    Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
    Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.
    Dryden NH; Broome LR; Dudbridge F; Johnson N; Orr N; Schoenfelder S; Nagano T; Andrews S; Wingett S; Kozarewa I; Assiotis I; Fenwick K; Maguire SL; Campbell J; Natrajan R; Lambros M; Perrakis E; Ashworth A; Fraser P; Fletcher O
    Genome Res; 2014 Nov; 24(11):1854-68. PubMed ID: 25122612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
    Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
    Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.
    Walavalkar K; Saravanan B; Singh AK; Jayani RS; Nair A; Farooq U; Islam Z; Soota D; Mann R; Shivaprasad PV; Freedman ML; Sabarinathan R; Haiman CA; Notani D
    Nat Commun; 2020 Jul; 11(1):3598. PubMed ID: 32680982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
    Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
    Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
    Wright JB; Brown SJ; Cole MD
    Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
    Ling H; Spizzo R; Atlasi Y; Nicoloso M; Shimizu M; Redis RS; Nishida N; Gafà R; Song J; Guo Z; Ivan C; Barbarotto E; De Vries I; Zhang X; Ferracin M; Churchman M; van Galen JF; Beverloo BH; Shariati M; Haderk F; Estecio MR; Garcia-Manero G; Patijn GA; Gotley DC; Bhardwaj V; Shureiqi I; Sen S; Multani AS; Welsh J; Yamamoto K; Taniguchi I; Song MA; Gallinger S; Casey G; Thibodeau SN; Le Marchand L; Tiirikainen M; Mani SA; Zhang W; Davuluri RV; Mimori K; Mori M; Sieuwerts AM; Martens JW; Tomlinson I; Negrini M; Berindan-Neagoe I; Foekens JA; Hamilton SR; Lanza G; Kopetz S; Fodde R; Calin GA
    Genome Res; 2013 Sep; 23(9):1446-61. PubMed ID: 23796952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PVT1: a rising star among oncogenic long noncoding RNAs.
    Colombo T; Farina L; Macino G; Paci P
    Biomed Res Int; 2015; 2015():304208. PubMed ID: 25883951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
    Prokunina-Olsson L; Hall JL
    Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy.
    Amjadi-Moheb F; Paniri A; Akhavan-Niaki H
    Cancer Res; 2021 Apr; 81(8):1925-1936. PubMed ID: 33472888
    [No Abstract]   [Full Text] [Related]  

  • 19. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
    Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
    Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.
    Tuupanen S; Yan J; Turunen M; Gylfe AE; Kaasinen E; Li L; Eng C; Culver DA; Kalady MF; Pennison MJ; Pasche B; Manne U; de la Chapelle A; Hampel H; Henderson BE; Marchand LL; Hautaniemi S; Askhtorab H; Smoot D; Sandler RS; Keku T; Kupfer SS; Ellis NA; Haiman CA; Taipale J; Aaltonen LA
    Cancer Genet; 2012; 205(1-2):25-33. PubMed ID: 22429595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.